Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Active, Not Recruiting

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

NCT07005336

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Chest Hospital Beijing, China
  • Binzhou Medical University Hospital Binzhou, China
  • Sichuan Cancer Hospital Chengdu, China
  • Chongqing University Three Gorges Hospital Chongqing, China
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

NCT06984588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Anyang Tumour Hospital Anyang, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Bejing Chao-Yang Hospital, Capital Medical University Beijing, China
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, China
View all 64 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

NCT02779751

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Highlands Oncology Group - Duplicate 2 Springdale, Arkansas, United States
  • Univ of California San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI

NCT05601973

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chu Angers Angers, France
  • Centre Hospitalier d'Avignon Avignon, France
  • Centre Léon Bérard Lyon, France
  • AO SM Misericorida Perugia Perugia, Italy
View all 18 locations
View Trial Details
Active, Not Recruiting

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

NCT05845671

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • Outpatient CTRC Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

NCT05074810

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Rocky Mountain Cancer Center, LLP Boulder, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center, MedStar Georgetown Cancer Institute, Washington D.C., District of Columbia, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
View all 35 locations
View Trial Details

Related conditions